Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Transpl Infect Dis. 2013 Feb 21;15(3):233–242. doi: 10.1111/tid.12060

Table 3.

Distribution of 106 invasive mold infections (IMI) among transplant recipients

IMI HSCT1
N=44 (%)
SOT2
N=62 (%)
Lung
N=21 (%)
Kidney
N=18 (%)
Liver
N=17 (%)
Heart
N=6 (%)
Aspergillus species 28 (64.3) 41 (66.1) 17 (80.9) 10 (55.6) 11 (64.7) 3 (50.0)
    A. flavus 3 (10.7) 4 (9.8) 2 (11.8) 1 (10.0) 1 (9.1) 0
    A. fumigatus 18 (64.3) 27 (65.9) 10 (58.8) 9 (90.0) 6 (54.5) 2 (66.7)
    A. niger 3 (10.7) 4 (9.8) 2 (11.8) 0 1 (9.1) 1 (33.3)
    A. terreus 1 (3.6) 1 (2.4) 1 (5.9) 0 0 0
    A. versicolor 0 1 (2.4) 0 0 1 (9.1) 0
    Other3 3 (10.7) 4 (9.8) 2 (11.8) 0 2 (18.2) 0

Zygomycetes 1 (2.3) 85 (12.9) 1 (4.8) 3 (16.7) 3 (17.5) 1 (16.7)
    Rhizopus 0 5 (62.5) 1 (100) 1 (33.3) 2 (66.7) 1(100)
    Other4 1 3 (37.5) 0 2 (66.7) 1 (33.3) 0

Fusarium species 3 (6.8) 1 (1.6) 0 1 (5.6) 0 0

Scedosporium species 2 (4.5) 1 (1.6) 0 0 1 (5.9) 0

Other5 10 (22.7) 7 (11.3) 3 (14.3) 1 (5.6) 1 (5.9) 2 (33.3)
1

Two of 44 patients had an autologous HSCT: one with Scedosporium species and another with other mold infection.

2

Four patients underwent >1 SOTs, and were not included in this Table.

3

Other Aspergillus species were not identified.

4

Other Zygomycetes included: Cunninghamella (n=1), Mucor (n=1), and not speciated Zygomycetes (n=1).

5

Other molds included: Cladosporium (n=1), Paecilomyces species (n=3), Acremonium (n=1), and other not speciated molds (n=12).

HSCT, hematopoietic stem cell transplant; SOT, solid organ transplant.